Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.

European review for medical and pharmacological sciences

Volumn 17, Issue 3, 2013, Pages 285-291

  Mahmoudi, L ^a   Mohammadpour, A H ^b   Ahmadi, A ^b   Niknam, R ^b   Mojtahedzadeh, M ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CREATININE;

ADULT; APACHE; ARTICLE; BIOLOGICAL MODEL; BLOOD; CLINICAL TRIAL; CRITICAL ILLNESS; DOSE RESPONSE; DRUG MONITORING; FEMALE; GRAM NEGATIVE INFECTION; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SEPSIS; SEVERITY OF ILLNESS INDEX; TISSUE DISTRIBUTION; URINE;

ADULT; AMIKACIN; ANTI-BACTERIAL AGENTS; APACHE; CREATININE; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEMODYNAMICS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; SEPSIS; SEVERITY OF ILLNESS INDEX; TISSUE DISTRIBUTION;

EID: 84878990269     PISSN: 11283602     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)